JDP raises $17M in series A

JDP Therapeutics Inc. (Blue Bell, Pa.) said it raised $17 million in a series A round led by CoSci Med-Tech Co. Ltd. (Beijing, China).

JDP plans to start a Phase III study of lead candidate JDP-205, an IV formulation of an oral generic antagonist of the histamine H1 receptor ( HRH1) to treat acute allergic reactions in hospitals (see BioCentury, Jan. 9, 2012). ...